🚨 New Eli5a Paper Drop 🚨
"DeSci AI: Barriers & Opportunities for Mass Adoption"
A rare fusion of TradSci veterans, DeSci pioneers & the DeSci Alliance founder, this work charts a bold roadmap for scientific transformation in the age of AI.
"DeSci AI: Barriers & Opportunities for Mass Adoption"
A rare fusion of TradSci veterans, DeSci pioneers & the DeSci Alliance founder, this work charts a bold roadmap for scientific transformation in the age of AI.
❤1
Key innovations:
🧠 Token-based peer review
🔁 Incentivized replication & null results
🤖 AI-led misconduct detection
⚖️ Hybrid governance frameworks
Now live/open across:
📄 OSF: osf.io/xh7pm/
🔜 SocArXiv, arXiv, GitBook
🔁 ResearchHub: DOI 10.55277/researchhub.ztvwa5ui.3
🧬 Submitted to Nature
Not just a paper—this is a framework for resilient, open, and trusted science.
Join the discussion. Shape the future.
🧠 Token-based peer review
🔁 Incentivized replication & null results
🤖 AI-led misconduct detection
⚖️ Hybrid governance frameworks
Now live/open across:
📄 OSF: osf.io/xh7pm/
🔜 SocArXiv, arXiv, GitBook
🔁 ResearchHub: DOI 10.55277/researchhub.ztvwa5ui.3
🧬 Submitted to Nature
Not just a paper—this is a framework for resilient, open, and trusted science.
Join the discussion. Shape the future.
OSF
Decentralized Science Artificial Intelligence (DeSci AI): Barriers and Opportunities for Mass Adoption by the Scientific Community
Abstract:
The emergence of decentralized science (DeSci) and the potential for its acceleration through artificial intelligence (AI) presents both remarkable promise and formidable challenges for modern research. DeSci AI platforms use blockchain-based, openly…
The emergence of decentralized science (DeSci) and the potential for its acceleration through artificial intelligence (AI) presents both remarkable promise and formidable challenges for modern research. DeSci AI platforms use blockchain-based, openly…
❤1
For those new to the group - Eli5a is Ai Agent focused in the DeSci narrative helping to spread research simplification through scientific communication on X.
80% of the US population is health illiterate and Eli5a is bridging that gap to simplify science so the layman has access to the same science as Doctors & Scientist.
What would you rather read? A scientific paper with Jargon or an easy to read breakdown with no Jargon?
80% of the US population is health illiterate and Eli5a is bridging that gap to simplify science so the layman has access to the same science as Doctors & Scientist.
What would you rather read? A scientific paper with Jargon or an easy to read breakdown with no Jargon?
❤3
📣 Been quiet here, but for good reason…
Our recent paper on Eli5a just dropped — and it’s making waves. Months in the making, this marks a milestone in our journey. Since March, we’ve added two Harvard PhDs to the team and joined forces with leading DeSci voices. TradSci × DeSci is in motion.
🇮🇹 Today, our science lead is presenting Eli5a’s latest AI pathology insights live in Italy.
What’s next?
✅ We’ve begun the CB checkmark process — authenticity matters. Given CB is launching v2, they are busy ⚡️
📖 Eli5a’s reading level now outperforms GPT & Claude in recent tests (we’re happy to share results).
🧠 It can now break down complex health topics by scanning influencer chatter on X — check our latest Long Covid post.
And yes, our next paper is already in progress. No other AI agent in DeSci has peer-reviewed papers backing its science. Eli5a is building the future — transparently, collaboratively, and openly.
Stay tuned.
Our recent paper on Eli5a just dropped — and it’s making waves. Months in the making, this marks a milestone in our journey. Since March, we’ve added two Harvard PhDs to the team and joined forces with leading DeSci voices. TradSci × DeSci is in motion.
🇮🇹 Today, our science lead is presenting Eli5a’s latest AI pathology insights live in Italy.
What’s next?
✅ We’ve begun the CB checkmark process — authenticity matters. Given CB is launching v2, they are busy ⚡️
📖 Eli5a’s reading level now outperforms GPT & Claude in recent tests (we’re happy to share results).
🧠 It can now break down complex health topics by scanning influencer chatter on X — check our latest Long Covid post.
And yes, our next paper is already in progress. No other AI agent in DeSci has peer-reviewed papers backing its science. Eli5a is building the future — transparently, collaboratively, and openly.
Stay tuned.
❤2
🚨 Eli5a Takes the Global Stage 🚨
At this year’s IADR General Session in Barcelona — the premier international forum for dental and oral health research — Eli5a’s Chief Scientific Officer was honored as the guest speaker for the AI symposium.
His talk, “AI-Powered Spatial Multi-Omics for High-Risk Oral Precancerous Lesions,” was not just another presentation — it was a signal. A signal that Eli5a is setting the pace in a space crowded with noise but starved for substance.
We weren’t just invited.
We were the only ones invited.
While others chase headlines, Eli5a is driving research that earns seats at the world’s most respected tables. This is more than validation — it’s momentum.
For investors seeking real traction in AI-driven healthcare, the signal couldn’t be clearer:
Eli5a isn’t watching the future unfold. We’re building it.
At this year’s IADR General Session in Barcelona — the premier international forum for dental and oral health research — Eli5a’s Chief Scientific Officer was honored as the guest speaker for the AI symposium.
His talk, “AI-Powered Spatial Multi-Omics for High-Risk Oral Precancerous Lesions,” was not just another presentation — it was a signal. A signal that Eli5a is setting the pace in a space crowded with noise but starved for substance.
We weren’t just invited.
We were the only ones invited.
While others chase headlines, Eli5a is driving research that earns seats at the world’s most respected tables. This is more than validation — it’s momentum.
For investors seeking real traction in AI-driven healthcare, the signal couldn’t be clearer:
Eli5a isn’t watching the future unfold. We’re building it.
🔥9
Update from the Eli5a Science Team – We’ve begun targeting highly controversial and impactful scientific posts, particularly those that may promote misinformation. Our goal is to debunk false or misleading claims and provide the scientifically uninitiated public with clear, accurate, and easy-to-understand information.
An upcoming post will focus on a controversial new supplement that has been aggressively promoted in the mass market—despite clear disregard for its underlying carcinogenic risk profile.
Stay tuned for more updates.
An upcoming post will focus on a controversial new supplement that has been aggressively promoted in the mass market—despite clear disregard for its underlying carcinogenic risk profile.
Stay tuned for more updates.
❤2
Check out our last spaces session! New spaces session coming later this month:
https://x.com/andrewhemingway/status/1906753395483922792?s=46&t=uq61w-xRqKcGZZYSY5wpmQ
https://x.com/andrewhemingway/status/1906753395483922792?s=46&t=uq61w-xRqKcGZZYSY5wpmQ
X (formerly Twitter)
Andrew Hemingway (@AndrewHemingway) on X
https://t.co/mjdOb67x9F